Prometheus | Protein Stability + Aggregation + Particle Sizing
-
1:41
Prometheus Panta: The new gold standard for biologics characterization
Choosing the right stability characterization tool for your biologics research is a big commitment. You’re going to be screening and optimizing lots of candidates, and you’ll need data on thermal stab
-
How early discovery and development teams use Dynamic Light Scattering to de-risk downstream biologics development
As a discovery or early development scientist, you’re tasked with identifying the most promising biologics candidates. Your hard work during early development enables straightforward and efficient...
-
4:51
Four integrated technologies for Biologics developability assessment
The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics
-
The biologics researcher's guide to DLS
-
Top 8 biologics conferences of 2023 at a glance
Use this downloadable list of 2023 biologics conferences to select which one to attend. Learn when and where they’ll happen, who’ll be there, and the main focus.
-
Ready to tackle your challenging stability characterizations?
Discover tools -
34:16
DLS easily explained: What it tells you about your protein
Join this webinar to learn about the physical phenomenon that drives Dynamic Light Scattering (DLS), and see a few examples of how DLS gives you deeper insights.
-
2:34
How 2bind identifies the best buffer for a vaccine antigen target with Prometheus Panta
Discover how 2bind applied multi-parameter characterization from a single experiment to find the optimal buffer for a vaccine antigen target.
-
Biologics developability: learn how Merck uses Prometheus Panta to create developability profiles for their mAbs
-
Select the best biologics candidates with high-quality, multi-parameter stability characterization
-
1:31
How Janssen optimizes the stability of a therapeutic mAb
Discover how Janssen improved the stability of a promising prostate cancer targeting mAb. You’ll learn why it is important to optimize stability measurements of a therapeutic mAb.
-
Use stability profiling to build more effective gene therapy vectors with Prometheus Panta
-
NanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs
SOUTH SAN FRANCISCO, Calif Feb 16 2022 — NanoTemper Technologies today announced the addition of Static Light Scattering (SLS) to their wildly successful Prometheus Panta, turning their instrument...
-
14:07
Serotyping: why, when, and how to assess your AAV therapeutic to get it approved
When you develop an AAV therapeutic, you need to assess many key parameters, or Critical Quality Attributes (CQAs), in order to track progress and, ultimately, get your therapeutic approved. As part
-
Ways light scattering technologies help you if you’re in gene therapy
-
8 biologics conferences you won’t want to miss in 2023
When you’re part of an industry that moves quickly, it’s important to keep up. You hear about biotherapeutics approvals, and big pharma news, but nothing matches the biologics conference experience.
-
Learn the pros and cons of these 3 methods to serotype your AAV gene therapy vectors
-
5 benefits of optimizing your formulation buffer to get your AAV therapeutic approved
As a gene therapy scientist, you face an abundance of challenges when working to build an effective AAV therapeutic. Many steps of the development workflow have yet to be standardized and the...
-
Four technologies to profile your AAVs
-
How Merck KGaA uses light scattering measurements for better developability assessment of biologic therapeutics
-
How stability studies get your mAb candidate FDA-approved
-
Loading more...